Motivational Program for Smokers Enrolled in a Methadone Maintenance Program

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Rhode Island Hospital Comprehensive Cancer Center National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00278226

Purpose

RATIONALE: Stop-smoking programs may help patients stop smoking and prevent cancer from forming.

PURPOSE: This clinical trial is studying how well a motivational program works in helping smokers enrolled in a methadone maintenance program quit smoking.

Condition	Intervention
Unspecified Adult Solid Tumor, Protocol Specific	Procedure: educational intervention Procedure: smoking cessation intervention

MedlinePlus related topics: Cancer Quitting Smoking Smoking

Drug Information available for: Methadone Methadone hydrochloride

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Open Label
Official Title:	Smoking Cessation Among Methadone Maintained Patients

Further study details as provided by National Cancer Institute (NCI):

Estimated Enrollment:	400
Study Start Date:	June 2001

Detailed Description:

OBJECTIVES:

Determine the efficacy of a brief motivational intervention on smoking cessation in smokers enrolled in a methadone maintenance program.

OUTLINE: Patients are assigned to 1 of 2 groups.

Group 1: Patients undergo assessment at baseline and at 1, 3, and 6 months.
Group 2: Patients receive a brief motivational intervention at the time of their baseline assessment and undergo assessment as in group 1.

All patients will be offered a 2- to 3-month supply of nicotine patches.

PROJECTED ACCRUAL: A total of 400 patients will be accrued for this study.

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

DISEASE CHARACTERISTICS:

Must be currently enrolled in a methadone maintenance program
Smokes at least 10 cigarettes a day

PATIENT CHARACTERISTICS:

Not pregnant
No concurrent medical condition that precludes the use of nicotine patches

PRIOR CONCURRENT THERAPY:

No concurrent use of other nicotine replacement therapy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00278226

Locations

United States, Rhode Island
Rhode Island Hospital Comprehensive Cancer Center
Providence, Rhode Island, United States, 02903

Sponsors and Collaborators

Rhode Island Hospital Comprehensive Cancer Center

National Cancer Institute (NCI)

Investigators

Study Chair:

Michael Stein, MD

Rhode Island Hospital Comprehensive Cancer Center

More Information

Clinical trial summary from the National Cancer Institute's PDQ® database This link exits the ClinicalTrials.gov site

Study ID Numbers:	CDR0000452798, RIH-0076-98
Study First Received:	January 16, 2006
Last Updated:	July 23, 2008
ClinicalTrials.gov Identifier:	NCT00278226
Health Authority:	United States: Federal Government

Keywords provided by National Cancer Institute (NCI):

unspecified adult solid tumor, protocol specific

Study placed in the following topic categories:

Methadone
Smoking

ClinicalTrials.gov processed this record on January 16, 2009